KM
AGN

Kalos Management’s Allergan plc AGN Stock Holding History

Kalos Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-952
Closed -$227K – 134
2017
Q1 		$227K Buy
+952
New +$222K 0.16% 123
2016
Q4 		– Sell
-1,319
Closed -$304K – 154
2016
Q3 		$304K Buy
+1,319
New +$322K 0.26% 106
2015
Q4 		– Hold
0
– – – 312

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Kalos Management's AGN Position: Q2 2017 in Review

Kalos Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 952 shares — an estimated $227K sold.

Kalos Management first reported a position in AGN in Q3 2016 and held it in 2 quarters. The position peaked at $304K in Q3 2016. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Kalos Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Kalos Management sold 952 Allergan plc shares in Q2 2017, an estimated $227K.
  • Kalos Management first reported a position in Allergan plc in Q3 2016 and held it in 2 quarters.
  • Kalos Management's Allergan plc position peaked at $304K in Q3 2016.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Kalos Management's 13F filing for Q2 2017, filed 15 Aug 2017.